Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial

Autor: Roncero-Ramos, Irene, Gutierrez-Mariscal, Francisco M., Gomez-Delgado, Francisco, Villasanta-Gonzalez, Alejandro, Torres-Peña, Jose D., Cruz-Ares, Silvia De La, Rangel-Zuñiga, Oriol A., Luque, Raul M., Ordovas, Jose M., Delgado-Lista, Javier, Perez-Martinez, Pablo, Camargo, Antonio, Alcalá-Diaz, Juan F., Lopez-Miranda, Jose
Zdroj: In Translational Research December 2021 238:12-24
Databáze: ScienceDirect
Externí odkaz: